Global Neurodegenerative Disease Market Growth (Status and Outlook) 2023-2029

Global Neurodegenerative Disease Market Growth (Status and Outlook) 2023-2029

Neurodegenerative disease or neurodegeneration refers to the progressive damage or wear and tear of the nerve cells. Neurodegenerative disease causes loss of abilities like decision making and eventually memory loss.

LPI (LP Information)' newest research report, the “Neurodegenerative Disease Industry Forecast” looks at past sales and reviews total world Neurodegenerative Disease sales in 2022, providing a comprehensive analysis by region and market sector of projected Neurodegenerative Disease sales for 2023 through 2029. With Neurodegenerative Disease sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Neurodegenerative Disease industry.

This Insight Report provides a comprehensive analysis of the global Neurodegenerative Disease landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Neurodegenerative Disease portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Neurodegenerative Disease market.

This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Neurodegenerative Disease and breaks down the forecast by type, by application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Neurodegenerative Disease.

The global Neurodegenerative Disease market size is projected to grow from US$ 6850.9 million in 2022 to US$ 8561.2 million in 2029; it is expected to grow at a CAGR of 3.2% from 2023 to 2029.

United States market for Neurodegenerative Disease is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.

China market for Neurodegenerative Disease is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.

Europe market for Neurodegenerative Disease is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.

Global key Neurodegenerative Disease players cover Novartis, Pfizer, Merck Serono, Biogen Idec, TEVA, UCB, Boehringer Ingelheim, Sanofi and GlaxoSmithKline, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2022.

This report presents a comprehensive overview, market shares, and growth opportunities of Neurodegenerative Disease market by product type, application, key players and key regions and countries.

Market Segmentation:

Segmentation by type
NMDA
SSRIs
Dopamine Inhibitors

Segmentation by application
Parkinson’s Disease
Huntington Disease
Amyotrophic Lateral Sclerosis
Alzheimer’s Disease

This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries

The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.
Novartis
Pfizer
Merck Serono
Biogen Idec
TEVA
UCB
Boehringer Ingelheim
Sanofi
GlaxoSmithKline
Livzon Pharmaceutical
Haisco Pharmaceutical
Jingxin Pharmaceutical
Dongcheng Biochemicals
Hisun Pharmaceutical
Luye Pharma
Ark Pharmaceutical
Kanghong Pharmaceutical
Huahai Pharmaceutical
BORA PHARMACEUTICALS

Please note: The report will take approximately 2 business days to prepare and deliver.